Eagle Pharmaceuticals Announces New Patents Issued for Bendeka

09:34 EST 21 Feb 2017 | Businesswire

This article has expired, however you can still download the PDF.
-- Bendeka protected by 10 patents running from 2026 through 2033 – -- Total of nine Orange Book listed patents – -- Additional four patents allowed -- Eagle Pharmaceuticals, Inc. (Nasdaq:EGRX) (“Eagl...

Other Sources for this Article

Investor Relations for Eagle Pharmaceuticals, Inc.:
Lisa M. Wilson, 212-452-2793


More From BioPortfolio on "Eagle Pharmaceuticals Announces New Patents Issued for Bendeka"

Quick Search


Relevant Topics

Drug Approvals
In order to become availible to pateints, drugs need to undergo a number of phases of clinical trials to test their efficacy and safty and to then be authorised by the drug approval organistion in each respective country. This is the FDA in the USA and N...

Drug Discovery
Clinical Approvals Clinical Trials Drug Approvals Drug Delivery Drug Discovery Generics Drugs Prescription Drugs In the fields of medicine, biotechnology and pharmacology, drug discovery is the process by which drugs are dis...